Small molecule inhibitors reveal Niemann–Pick C1 is essential for Ebola virus infection M Côté, J Misasi, T Ren, A Bruchez, K Lee, CM Filone, L Hensley, Q Li, ... Nature 477 (7364), 344-348, 2011 | 824 | 2011 |
Cross-sectional evaluation of humoral responses against SARS-CoV-2 spike J Prévost, R Gasser, G Beaudoin-Bussières, J Richard, R Duerr, ... Cell Reports Medicine 1 (7), 2020 | 228 | 2020 |
Filoviruses require endosomal cysteine proteases for entry but exhibit distinct protease preferences J Misasi, K Chandran, JY Yang, B Considine, CM Filone, M Côté, ... Journal of virology 86 (6), 3284-3292, 2012 | 134 | 2012 |
Divergent SARS-CoV-2 variant emerges in white-tailed deer with deer-to-human transmission B Pickering, O Lung, F Maguire, P Kruczkiewicz, JD Kotwa, T Buchanan, ... Nature Microbiology 7 (12), 2011-2024, 2022 | 131 | 2022 |
Delivery of MicroRNAs by Chitosan Nanoparticles to Functionally Alter Macrophage Cholesterol Efflux in Vitro and in Vivo MA Nguyen, H Wyatt, L Susser, M Geoffrion, A Rasheed, AC Duchez, ... ACS nano 13 (6), 6491-6505, 2019 | 114 | 2019 |
Structural basis and mode of action for two broadly neutralizing antibodies against SARS-CoV-2 emerging variants of concern W Li, Y Chen, J Prévost, I Ullah, M Lu, SY Gong, A Tauzin, R Gasser, ... Cell reports 38 (2), 2022 | 105 | 2022 |
Contribution of single mutations to selected SARS-CoV-2 emerging variants spike antigenicity SY Gong, D Chatterjee, J Richard, J Prévost, A Tauzin, R Gasser, Y Bo, ... Virology 563, 134-145, 2021 | 95 | 2021 |
Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses A Tauzin, SY Gong, G Beaudoin-Bussières, D Vézina, R Gasser, L Nault, ... Cell host & microbe 30 (1), 97-109. e5, 2022 | 89 | 2022 |
Differential induction of apoptosis by tumor necrosis factor-related apoptosis-inducing ligand in human ovarian carcinoma cells D Lane, A Cartier, S L'Espérance, M Côté, C Rancourt, A Piché Gynecologic oncology 93 (3), 594-604, 2004 | 77 | 2004 |
Acquired resistance to TRAIL-induced apoptosis in human ovarian cancer cells is conferred by increased turnover of mature caspase-3 D Lane, M Côté, R Grondin, MC Couture, A Piché Molecular cancer therapeutics 5 (3), 509-521, 2006 | 64 | 2006 |
SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-week interval between doses D Chatterjee, A Tauzin, L Marchitto, SY Gong, M Boutin, C Bourassa, ... Cell reports 38 (9), 2022 | 59 | 2022 |
Highly divergent white-tailed deer SARS-CoV-2 with potential deer-to-human transmission B Pickering, O Lung, F Maguire, P Kruczkiewicz, JD Kotwa, T Buchanan, ... BioRxiv, 2022.02. 22.481551, 2022 | 59 | 2022 |
Ebola virus requires phosphatidylinositol (3, 5) bisphosphate production for efficient viral entry S Qiu, A Leung, Y Bo, RA Kozak, SP Anand, C Warkentin, ... Virology 513, 17-28, 2018 | 57 | 2018 |
Jaagsiekte sheep retrovirus utilizes a pH-dependent endocytosis pathway for entry P Bertrand, M Côté, YM Zheng, LM Albritton, SL Liu Journal of virology 82 (5), 2555-2559, 2008 | 52 | 2008 |
Fusogenicity of Jaagsiekte sheep retrovirus envelope protein is dependent on low pH and is enhanced by cytoplasmic tail truncations M Côté, YM Zheng, LM Albritton, SL Liu Journal of virology 82 (5), 2543-2554, 2008 | 46 | 2008 |
Enzootic nasal tumor virus envelope requires a very acidic pH for fusion activation and infection M Côté, TJ Kucharski, SL Liu Journal of virology 82 (18), 9023-9034, 2008 | 45 | 2008 |
Bcl-2 decreases cell proliferation and promotes accumulation of cells in S phase without affecting the rate of apoptosis in human ovarian carcinoma cells S Bélanger, M Côté, D Lane, S L'Espérance, C Rancourt, A Piché Gynecologic oncology 97 (3), 796-806, 2005 | 42 | 2005 |
Receptor binding and low pH coactivate oncogenic retrovirus envelope-mediated fusion M Côté, YM Zheng, SL Liu Journal of virology 83 (22), 11447-11455, 2009 | 37 | 2009 |
Inhibition of Ebola virus infection: identification of Niemann-Pick C1 as the target by optimization of a chemical probe K Lee, T Ren, M Côté, B Gholamreza, J Misasi, A Bruchez, ... ACS medicinal chemistry letters 4 (2), 239-243, 2013 | 36 | 2013 |
A triple-drug nanotherapy to target breast cancer cells, cancer stem cells, and tumor vasculature S El-Sahli, K Hua, A Sulaiman, J Chambers, L Li, E Farah, S McGarry, ... Cell death & disease 12 (1), 8, 2021 | 35 | 2021 |